We just received data on a new analyst forecast for $PTCT. B of A Securities gave a rating of 'Buy' for $PTCT.
$PTCT Analyst Ratings
Wall Street analysts have issued reports on $PTCT in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Buy" rating on 08/20/2025
- Wells Fargo issued a "Overweight" rating on 08/08/2025
- RBC Capital issued a "Outperform" rating on 08/08/2025
- Truist Securities issued a "Buy" rating on 07/29/2025
- UBS issued a "Buy" rating on 07/29/2025
- Cantor Fitzgerald issued a "Overweight" rating on 07/29/2025
- Baird issued a "Outperform" rating on 05/07/2025
To track analyst ratings and price targets for $PTCT, check out Quiver Quantitative's $PTCT forecast page.
$PTCT Price Targets
Multiple analysts have issued price targets for $PTCT recently. We have seen 12 analysts offer price targets for $PTCT in the last 6 months, with a median target of $68.5.
Here are some recent targets:
- Tazeen Ahmad from B of A Securities set a target price of $76.0 on 08/20/2025
- Brian Abrahams from RBC Capital set a target price of $63.0 on 08/08/2025
- Tiago Fauth from Wells Fargo set a target price of $79.0 on 08/08/2025
- Joon Lee from Truist Securities set a target price of $86.0 on 07/29/2025
- Kristen Kluska from Cantor Fitzgerald set a target price of $120.0 on 07/29/2025
- Colin Bristow from UBS set a target price of $80.0 on 07/29/2025
- Gena Wang from Barclays set a target price of $46.0 on 07/29/2025
$PTCT Insider Trading Activity
$PTCT insiders have traded $PTCT stock on the open market 38 times in the past 6 months. Of those trades, 0 have been purchases and 38 have been sales.
Here’s a breakdown of recent trading of $PTCT stock by insiders over the last 6 months:
- MARK ELLIOTT BOULDING (EXEC. VP AND CLO) has made 0 purchases and 13 sales selling 99,513 shares for an estimated $5,244,588.
- MATTHEW B. KLEIN (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 4 sales selling 21,335 shares for an estimated $1,082,748.
- ERIC PAUWELS (CHIEF BUSINESS OFFICER) has made 0 purchases and 7 sales selling 14,165 shares for an estimated $777,680.
- STEPHANIE OKEY sold 5,000 shares for an estimated $270,000
- PIERRE GRAVIER (CHIEF FINANCIAL OFFICER) has made 0 purchases and 3 sales selling 4,851 shares for an estimated $241,448.
- NEIL GREGORY ALMSTEAD (CHIEF TECHNICAL OPS OFFICER) has made 0 purchases and 4 sales selling 2,946 shares for an estimated $147,627.
- LEE SCOTT GOLDEN (EVP & CHIEF MEDICAL OFFICER) has made 0 purchases and 3 sales selling 2,654 shares for an estimated $130,159.
- CHRISTINE MARIE UTTER (SVP, CHIEF ACCOUNTING OFFICER) has made 0 purchases and 2 sales selling 1,757 shares for an estimated $88,043.
- ALLAN STEVEN JACOBSON sold 1,230 shares for an estimated $63,369
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PTCT Hedge Fund Activity
We have seen 166 institutional investors add shares of $PTCT stock to their portfolio, and 137 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAMBER CAPITAL MANAGEMENT LP removed 1,500,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $73,260,000
- POINT72 ASSET MANAGEMENT, L.P. removed 1,373,573 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $67,085,305
- BLACKSTONE INC. removed 1,059,574 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $53,995,891
- D. E. SHAW & CO., INC. added 992,418 shares (+68.7%) to their portfolio in Q2 2025, for an estimated $48,469,695
- BANK OF AMERICA CORP /DE/ added 865,281 shares (+167.6%) to their portfolio in Q2 2025, for an estimated $42,260,324
- PACER ADVISORS, INC. added 740,817 shares (+inf%) to their portfolio in Q2 2025, for an estimated $36,181,502
- WELLINGTON MANAGEMENT GROUP LLP removed 725,034 shares (-13.4%) from their portfolio in Q2 2025, for an estimated $35,410,660
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
